ENDOCYTE INC: 10-K filed 2012-03-28
What ENDOCYTE INC reported in its annual report filed 2012-03-28 (fiscal FY 2011): 27 published measures, 71 facts as tagged in accession 0001193125-12-136853.
This filing
- Form
- 10-K (annual report)
- Filed
- 2012-03-28
- Fiscal period
- fiscal FY 2011
- Accession
- 0001193125-12-136853 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ENDOCYTE INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 131,675,104 | USD | |
| At 2010-12-31 | 21,214,218 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 18,303,181 | USD | |
| At 2010-12-31 | 28,325,758 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 113,371,923 | USD | |
| At 2010-12-31 | -96,911,023 | USD | |
| At 2009-12-31 | -76,057,563 | USD | |
| At 2008-12-31 | -59,412,369 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 61,352,483 | USD | |
| At 2010-12-31 | 16,872,783 | USD | |
| At 2009-12-31 | 8,699,372 | USD | |
| At 2008-12-31 | 4,878,554 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -40,531,613 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -20,092,722 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -17,005,685 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -34,584,616 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -20,745,146 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -15,396,341 | USD | 365 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 234,969 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 200,527 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 155,441 | USD | 365 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 191,023 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 3,000,000 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 146,381,132 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 13,907,808 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 21,083,496 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -67,311,098 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 15,010,749 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -1,866,337 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | -138,600,520 | USD | |
| At 2010-12-31 | -98,068,907 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 1,107,851 | USD | |
| At 2010-12-31 | 863,008 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 1,960,345 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 523,562 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 381,877 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -38,636,723 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -20,599,966 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -15,738,000 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 129,756,024 | USD | |
| At 2010-12-31 | 20,050,225 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 1,987,873 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 1,064,556 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 1,435,988 | USD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 5,470,002 | USD | |
| At 2010-12-31 | 7,673,034 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 2,125,500 | USD | |
| At 2010-12-31 | 755,208 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 38,827,746 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 20,599,966 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 18,738,000 | USD | 365 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 28,827,746 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 14,560,821 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 14,803,741 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 35,784,485 | shares | |
| At 2010-12-31 | 1,203,228 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | -6,264 | USD | |
| At 2010-12-31 | 0 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 811,229 | USD | |
| At 2010-12-31 | 300,985 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 665,477 | USD | |
| At 2010-12-31 | 1,305,496 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 10,000,000 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 6,039,145 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 3,934,259 | USD | 365 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 262,518 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 260,571 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 231,890 | USD | 365 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 943,024 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -118,140 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 493,263 | USD | 365 |
Inspect the source
- Entity
- ENDOCYTE INC / CIK 0001235007
- Captured
- SEC response SHA-256
fa7da76c073b3895ba6769212bf598e872bbf5f159d8c19a8ae123614d925339
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001235007.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))